@ResearchCat said in Order of Operation for Protocol Cycles:
Welcome! This is a big topic. My rule #1 is to go slow. Rule #2 is to know what you are researching, why, and what you hope to get out of it. And track results. (Yeah, keep a journal.)
Popular peptides often work on one of 3 general interaction pipelines. Josh Holyfield has a good video explaining which is which. It often doesn’t make sense to research 3 different things that all affect the same target.
I research Glow for extended periods(2-3 months) while also cycling CJC/Ipa or other GHRH and currently MOTS-C/NAD+ over shorter periods.
I think it is probably fine researching epitalon with pretty much anything else, though I usually research it when not running a bunch of other stuff(for no particular reason.)
So I guess if you are researching a protocol someone recommended that you trust, you can go ahead and follow that. If you want to see what specific results you get from a particular peptide, the fewer other things involved will help with that.
FWIW, I recently cycled off CJC/Ipa(assume no DAC) and GLOW, am currently researching MOTS-C/NAD+, also very low dose Tirz, and in a week or two will begin researching tesa and KLOW.
I tend to plan a lot, but in this area I am generally thinking a few months out and make changes when it seems appropriate. For stuff like epitalon that one generally researches 1-2 times a year, I have a mental note that I will run it around June or something.
I hope my rambling is helpful.
Thanks for the info.
